News

Physicians Committee for Responsible Medicine5h

New AI Model Rapidly Predicts Drug Binding Affinity With High Accuracy

Study in a Sentence: A new multi-component, transformer-based, open-source AI model, Boltz-2, predicts protein–drug binding ...

Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting

Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the ...

Simulations Plus (SLP) AI-Driven Drug Design Collaboration Yields Positive Results

Simulations Plus, Inc. (NASDAQ:SLP) is one of the top 10 medical AI companies to buy according to analysts. On July 29, the ...

Colorectal cancer study expands and optimizes 3D tumor models

Researchers from the Germans Trias i Pujol Research Institute (IGTP) have published a study in Scientific Reports that ...
EurekAlert!2d

New study expands and optimizes 3D models to investigate colorectal cancer

Researchers from the Cancer Genetics and Epigenetics group at IGTP have published a study in Scientific Reports presenting a ...

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.
Devdiscourse2d

From Code to Cure: Generative AI’s Role in Drug Discovery and Protein Engineering

This review explores how generative AI, through models like VAEs, GANs, transformers, and diffusion networks is ...